Leukemia

Allo-HCT With Unrelated Donor Tied to Better Outcomes in AML

Publish Date June 13, 2019

In active AML, outcomes superior for allo-HCT with unrelated donor than for cord blood transplantation

Less-Frequently Dosed Pegylated Asparaginase: Found as Safe and Effective as Standard Pegaspargase in Younger Patients With ALL

By

Susan Moench, PhD, PA-C

Publish Date June 3, 2019

Postinduction, median nadir serum asparaginase activity was similar in patients receiving either drug, suggesting a need for dosing optimization.

Octogenarians With Acute Myeloid Leukemia Have Poor Survival

Publish Date May 28, 2019

Overall survival 1.5 months; survival improved for those receiving chemotherapy

Patterns in Late Morbidity Burden Changed for Survivors of Pediatric ALL

By

Susan Moench, PhD, PA-C

Publish Date May 22, 2019

A retrospective cohort study from St Jude Children’s Research Hospital sought to determine how long-term effects of treatment have evolved for survivors of pediatric ALL.

The Cost of Cancer Treatment: Financial Toxicity in Acute Leukemia

By

Tom Greenhalgh

Publish Date May 22, 2019

What is the role of the clinician in managing financial toxicity?

Leukemia Clinical Trials

Clinical Trial: Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study) (CCLS)

Clinical trial focusing on the molecular epidemiology of childhood leukemia. Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study) (CCLS)

Clinical Trial: Genetic Study of Chronic Lymphocytic Leukemia Families

Clinical trial focusing on genetics and chronic lymphocytic leukemia. Genetic Study of Chronic Lymphocytic Leukemia Families

Clinical Trial: Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation

Clinical trial focusing on vaccine generation from chronic lymphocytic leukemia tumor cells. Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation

Clinical Trial: Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia

Clinical trial focusing on GNKG168. Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia

Clinical Trial: Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)

Clinical trial focusing on carfilzomib Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL). Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL) .